Department of Otorhinolaryngology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.
Department of Otorhinolaryngology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.
World Neurosurg. 2014 Dec;82(6 Suppl):S22-31. doi: 10.1016/j.wneu.2014.07.021.
Data from several centers worldwide have demonstrated that transnasal endoscopic surgery performed with or without a transcranial approach is capable of achieving radical resection of selected sinonasal malignancies. We report our experience with endoscopic management of sinonasal cancers, with emphasis on naso-ethmoidal malignancies encroaching on the anterior skull base.
Major series reporting results concerning the endoscopic endonasal approach with or without craniectomy for treatment of sinonasal and anterior skull base cancers were reviewed. Preoperative work-up, indications and exclusion criteria, surgical techniques, postoperative management, and adjuvant therapy are reported.
In the 2 largest series analyzed, the most common malignancies were adenocarcinoma (28%), olfactory neuroblastoma (14.5%), and squamous cell carcinoma (13.5%). The 5-year disease-specific survival rate ranged from 81.9%-87%, with no major differences in the mean follow-up time (34.1 months vs. 37 months).
Endoscopic endonasal resection performed with or without a transcranial approach, when properly planned and in expert hands, has an accepted role with precise indications in the surgeon's armamentarium for the treatment of sinonasal and skull base malignancies.
来自全球多个中心的数据表明,经鼻内镜手术联合或不联合颅面入路能够实现对选定的鼻腔鼻窦恶性肿瘤的根治性切除。我们报告了我们在鼻腔鼻窦恶性肿瘤内镜管理方面的经验,重点是累及前颅底的鼻腔-筛窦恶性肿瘤。
回顾了主要报道经鼻内镜联合或不联合颅面入路治疗鼻腔鼻窦和前颅底癌症的结果的大型系列研究。报告了术前检查、适应证和排除标准、手术技术、术后管理和辅助治疗。
在分析的 2 个最大系列中,最常见的恶性肿瘤是腺癌(28%)、嗅神经母细胞瘤(14.5%)和鳞状细胞癌(13.5%)。5 年疾病特异性生存率为 81.9%-87%,平均随访时间(34.1 个月与 37 个月)无显著差异。
经鼻内镜手术联合或不联合颅面入路,在经过精心规划和由专家实施时,在适当的适应证下,在治疗鼻腔鼻窦和颅底恶性肿瘤方面,是一种被广泛接受的治疗方法。